Plain-English translation of NCT06768528 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand whether a protein in your blood called galectin-3 can help predict which patients will develop an irregular heartbeat after coronary artery bypass graft surgery. This is an observational study, meaning researchers will watch and measure rather than give you a new treatment. They'll collect a blood sample before your surgery and follow you for one year afterward to see if galectin-3 levels are connected to heart rhythm problems.
Irregular heartbeats are a common complication after bypass surgery, affecting quality of life and recovery. If doctors could identify which patients are at highest risk by measuring this protein, they might be able to prevent the problem or treat it earlier.
You likely qualify if…
You likely don't qualify if…
You will have a blood sample taken within 24 hours before your bypass surgery. After your operation, the research team will monitor you during your hospital stay and then follow up with you for one year after you go home to see if you develop an irregular heartbeat and how your recovery goes. The study will compare your blood protein levels to your heart rhythm outcomes to find any connections.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Brazil